PMA device
PulseSelect Pulsed Field Ablation (PFA) system
Medtronic, Inc. · Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI, Class III) · First FDA decision Dec 13, 2023, newest Feb 17, 2026Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
Breakthrough-designated
Device trials
5
Naming "PulseSelect Pulsed Field"
MAUDE reports
15
Brand "PulseSelect Pulsed Field", since 2015
PubMed studies
0
Mentioning "PulseSelect Pulsed Field"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing PulseSelect Pulsed Field Ablation (PFA) system
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- PulseSelect Pulsed Field Ablation (PFA) systemPMA supplement
P230017-S009 · Decided Feb 17, 2026 · 102 days after receipt · Normal 180 Day Track
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
- PulseSelect Pulsed Field Ablation (PFA) systemPMA supplement
P230017-S007 · Decided Jun 27, 2025 · 42 days after receipt · Normal 180 Day Track No User Fee
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
- PulseSelect Pulsed Field Ablation (PFA) systemPMA supplement
P230017-S001 · Decided Jun 18, 2024 · 159 days after receipt · Normal 180 Day Track No User Fee
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
- Irreversible Electroporation for CancerLocal determinationIn effectL40205Palmetto GBAUpdated May 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "PulseSelect Pulsed Field", any status and sponsor, newest update first.
- Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial FibrillationNot yet recruiting
Medtronic Cardiac Ablation SolutionsPublic (MDT)
NCT07575828 · 320 participants (planned) · Start Oct 2026 · Primary completion Aug 2028
Device: PulseSelect Pulse Field Ablation (PFA) System · For: Paroxysmal Atrial Fibrillation (PAF); Persistent Atrial Fibrillation
- Cerebral Microembolization During Pulmonary Vein Isolation: Comparison of Different Pulsed Field Ablation SystemsPivotal-lookingNot yet recruiting
Ivan ZeljkovicAcademic, hospital or other
NCT07610018 · 100 participants (planned) · Start Jun 1, 2026 · Primary completion Jan 1, 2027
Device: Pulsed field ablation using PulseSelect system; Pulsed field ablation using Varipulse system and 3 more · For: Ablation of Arrhythmia's
Sites: Zagreb, Croatia · 2 sites in all
- PulseSelect Based Pulmonary Vein Isolation and Ablation in Patients With Atrial FibrillationCompleted
Tsiachris DimitriosAcademic, hospital or other
NCT07035288 · 40 participants · Start Nov 1, 2024 · Primary completion Jun 30, 2025
Device: EAM based Pulmonary Vein Isolation; Fluoro based pulmonary vein ablation · For: Atrial Fibrillation (AF); Catheter Ablation; Pulmonary Vein Isolation
Sites: Athens, Greece
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "PulseSelect Pulsed Field", and for the whole product code for context.
This brand
15 reports: 1 malfunction, 12 injury, 1 death
Whole product code QZI
10,522 reports: 5,457 malfunction, 4,777 injury, 245 death
Newest reports for this brand
MW6002687 · Received Sep 22, 2026 · Event dated Feb 9, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Pericardial Effusion
MW6001403 · Received Aug 24, 2026 · Event dated Aug 17, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Airway Obstruction
MW5184279 · Received Feb 23, 2026 · Event dated Jun 3, 2025
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Patient problem as coded: Low Blood Pressure/ Hypotension; Pericardial Effusion
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "PulseSelect Pulsed Field"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QZI.
- FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation CatheterFarapulse, Inc. · PMA 2026
- Volt PFA SystemAbbott Medical · PMA 2026
- VARIPULSE Catheter, TRUPULSE Generator with Connection Interface Unit (CIU)Biosense Webster, Inc. · PMA 2026
- Sphere-9 Catheter and Affera Ablation SystemMedtronic, Inc. · PMA 2026
- Globe® Catheter and Globe® Pulsed Field SystemKardium, Inc. · PMA 2026
- PulseSelect Pulse Field Ablation (PFA) CatheterMedtronic, Inc. · PMA 2026
- FARASTAR Pulsed Field Ablation (PFA) GeneratorFarapulse, Inc. · PMA 2025
- Globe® Pulsed Field SystemKardium, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.